CarsonAllaria Wealth Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-222
Closed -$639 388
2023
Q1
$639 Hold
222
﹤0.01% 351
2022
Q4
$1K Hold
222
﹤0.01% 302
2022
Q3
$1K Hold
222
﹤0.01% 301
2022
Q2
$1K Buy
+222
New +$1.14K ﹤0.01% 298

Other funds holding APYX

CarsonAllaria Wealth Management's APYX Position: Q2 2023 in Review

CarsonAllaria Wealth Management sold out of Apyx Medical (APYX) in Q2 2023, closing a stake of 222 shares — an estimated $639 sold.

CarsonAllaria Wealth Management first reported a position in APYX in Q2 2022 and held it in 4 quarters. The position peaked at $1K in Q4 2022. 56 funds tracked by Wall St. Rank hold APYX as of Q2 2023.

  • CarsonAllaria Wealth Management reported no remaining Apyx Medical position as of Q2 2023 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 222 Apyx Medical shares in Q2 2023, an estimated $639.
  • CarsonAllaria Wealth Management first reported a position in Apyx Medical in Q2 2022 and held it in 4 quarters.
  • CarsonAllaria Wealth Management's Apyx Medical position peaked at $1K in Q4 2022.
  • 56 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2023.

Based on CarsonAllaria Wealth Management's 13F filing for Q2 2023, filed 1 Aug 2023.